CG Oncology (CGON) Operating Margin (2023 - 2026)
CG Oncology posted quarterly Operating Margin of 6130.1% for Q1 2026, up 7503144.0% year-on-year from N/an in Q1 2025, and down 192.28% on a QoQ basis from 2097.33% in Q4 2025.
CG Oncology (CGON) has 4 years of Operating Margin data on file, last reported at 6130.1% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin rose 7503144.0% year-over-year to 6130.1%; the trailing twelve-month figure through Mar 2026 stood at 4238.99% (up 1606328.0% YoY), and the FY2025 full-year result was 4722.13%, up 534512.0% from the prior year.
- Operating Margin for Q1 2026 stood at 6130.1%, down from 2097.33% in the prior quarter.
- Across five years, Operating Margin topped out at 2097.33% in Q4 2025 and bottomed at 1935500.0% in Q4 2023.
- The 4-year median for Operating Margin is 8344.08% (2024), against an average of 208244.27%.
- The widest annual swing landed in 2024, when Operating Margin surged 192715592 bps; it then sank 7691409 bps in 2025.
- A 4-year view of Operating Margin shows it stood at 1935500.0% in 2023, then soared by 100 bps to 8344.08% in 2024, then soared by 75 bps to 2097.33% in 2025, then tumbled by 192 bps to 6130.1% in 2026.
- The last three Operating Margin figures came in at 6130.1% (Q1 2026), 2097.33% (Q4 2025), and 3068.97% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.02% |
| 10 | CG Oncology | 5.01 Bn | 5.01 Bn | -1.88 Mn | -6,130.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,130.10% |
| Dec 31, 2025 | -2,097.33% |
| Sep 30, 2025 | -3,068.97% |
| Mar 31, 2025 | -81,161.54% |
| Dec 31, 2024 | -8,344.08% |
| Sep 30, 2024 | -65,802.33% |
| Jun 30, 2024 | -23,290.99% |
| Mar 31, 2024 | -4,247.45% |
| Dec 31, 2023 | -1,935,500.00% |
| Sep 30, 2023 | -156,033.33% |
| Mar 31, 2023 | -5,010.82% |